Dr Vince Angelico

Chief Scientific Officer


As Chief Scientific Officer, Dr. Angelico leads the development of regulatory submission strategies for our clients across diverse FDA-regulated industries. His unique qualifications stem from a rich background in both the pharmaceutical and nicotine product sectors.

Before joining Accorto, Dr. Angelico built a successful career in the pharmaceutical industry, serving as the product development team leader at Merck & Co Pharmaceuticals as well as the Director of Manufacturing Operations at Boehringer Ingelheim (BI). Following his tenure in pharmaceuticals, Dr. Angelico spent seven years in the nicotine products space, where he played a crucial role in shaping the initial regulatory framework for newly regulated electronic cigarette applications, many of which are still currently under FDA review.

Dr. Angelico holds a B.S. in Chemistry from Virginia Commonwealth University and a Ph.D. in Analytical Chemistry from the University of Arizona.

Dr Vince Angelico will be speaking at the following sessions.

Back to speakers


Be the first to hear about exhibitors, speakers and what's on at our upcoming events.

Please note that this is not a show registration form. To register for FREE for WVS Dubai, please use the pink Register to attend button at the top of the page!

Which events are you interested in? *
I'm interested in *